Lycopene Ameliorates Hepatic Ischemia‐Reperfusion Injury in Rats by Suppressing HRD1 E3 Ubiquitin Ligase to Restore Nrf2 Signaling
Open Access
- 1 January 2025
- journal article
- Published by Wiley in Journal of Food Biochemistry
- Vol. 2025 (1)
Abstract
Background: Hepatic ischemia‐reperfusion injury (HIRI) is a critical clinical challenge, and lycopene, a natural carotenoid with antioxidant properties, has shown potential in mitigating organ damage. This research evaluated the therapeutic potential and mechanistic basis of lycopene against HIRI utilizing in vivo and in vitro approaches. Methods: A rat HIRI model and AML‐12 cell models (H 2 O 2 ‐induced oxidative stress and hypoxia/reoxygenation [H/R]) were established. Results: Lycopene significantly alleviated HIRI in rats, evidenced by improved hepatic histopathology (HE staining), restored antioxidant enzyme activities (SOD1 and GSH), and reduced proinflammatory cytokines (TNF‐α, IL‐6, and IL‐1β). Notably, HRD1, an E3 ubiquitin ligase, exhibited dynamic temporal expression: In mild HIRI (30 min ischemia/6 h reperfusion), HRD1 initially increased adaptively but declined thereafter, whereas severe ischemia (60 min) caused persistent HRD1 upregulation during reperfusion, exacerbating apoptosis and liver dysfunction. Lycopene treatment normalized HRD1 levels, reducing apoptosis markers (Bax, Cleaved‐Caspase‐3) and enhancing antiapoptotic Bcl‐2. In vitro, lycopene attenuated H 2 O 2 ‐ and H/R‐induced oxidative stress, inflammation, and apoptosis. Mechanistically, genetic manipulation of HRD1 (silencing or overexpression) confirmed that it targets Nrf2, the central regulator of antioxidant defense, for degradation. Lycopene suppressed HRD1‐mediated Nrf2 ubiquitination, thereby stabilizing Nrf2 and activating downstream antioxidant genes (HO‐1 and NQO1). Conclusions: These findings demonstrate that lycopene ameliorates HIRI by modulating the HRD1‐Nrf2 axis, highlighting its therapeutic potential via dual antioxidant and antiapoptotic mechanisms. This study provides novel insights into HRD1’s context‐dependent roles in HIRI and positions lycopene as a promising candidate for clinical translation.Keywords
This publication has 44 references indexed in Scilit:
- Liver ischemia reperfusion injury: Mechanisms, cellular pathways, and therapeutic approachesInternational Immunopharmacology, 2025
- Multimodal modulation of hepatic ischemia/reperfusion-induced injury by phytochemical agents: A mechanistic evaluation of hepatoprotective potential and safety profilesInternational Immunopharmacology, 2024
- HRD1-mediated ubiquitination of HDAC2 regulates PPARα-mediated autophagy and alleviates metabolic-associated fatty liver diseaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2024
- Ischemic preconditioning attenuates endoplasmic reticulum stress-dependent apoptosis of hepatocytes by regulating autophagy in hepatic ischemia-reperfusion injuryInternational Immunopharmacology, 2023
- E3 ubiquitin ligase ring finger protein 5 protects against hepatic ischemia reperfusion injury by mediating phosphoglycerate mutase family member 5 ubiquitinationHepatology, 2022
- Endoplasmic reticulum-associated degradation and beyond: The multitasking roles for HRD1 in immune regulation and autoimmunityJournal of Autoimmunity, 2020
- Resveratrol, an activator of SIRT1, improves ER stress by increasing clusterin expression in HepG2 cellsCell Stress and Chaperones, 2019
- Nano-liposomes of lycopene reduces ischemic brain damage in rodents by regulating iron metabolismFree Radical Biology and Medicine, 2018
- Decoding cell death signals in liver inflammationJournal of Hepatology, 2013
- Dissecting the ER-Associated Degradation of a Misfolded Polytopic Membrane ProteinCell, 2008